Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival.
centralised care
mortality
multimodal treatment
penile squamous cell carcinoma
population-based registry
relative survival
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
25 Feb 2024
25 Feb 2024
Historique:
medline:
26
2
2024
pubmed:
26
2
2024
entrez:
25
2
2024
Statut:
aheadofprint
Résumé
To evaluate penile squamous cell carcinoma (PSCC) incidence and centralisation trends in the Netherlands over the past three decades, as well as the effect of centralisation of PSCC care on survival. In the Netherlands PSCC care is largely centralised in one national centre of expertise (Netherlands Cancer Institute [NCI], Amsterdam). For this study, the Netherlands Cancer Registry, an independent nationwide cancer registry, provided per-patient data on age, clinical and pathological tumour staging, follow-up, and vital status. Patients with treatment at the NCI were identified and compared to patients who were treated at all other centres. The age-standardised incidence rate was calculated with the European Standard Population. The probability of death due to PSCC was estimated using the relative survival. Multivariable Cox regression analysis was performed to evaluate predictors of survival. A total of 3160 patients were diagnosed with PSCC between 1990 and 2020, showing a rising incidence (P < 0.001). Annual caseload increased at the NCI (1% in 1990, 65% in 2020) and decreased at other (regional) centres (99% to 35%). Despite a relatively high percentage of patients with T2-4 (64%) and N+ (33%) at the NCI, the 5-year relative survival was higher (86%, 95% confidence interval [CI] 82-91%) compared to regional centres (76%, 95% CI 73-80%, P < 0.001). Patients with a pathological T2 tumour were treated with glans-sparing treatment more often at the reference centre than at the regional centres (16% vs 5.0%, P < 0.001). After adjusting for age, histological grading, T-stage, presence of lymph node involvement and year of diagnosis, treatment at regional centres remained a predictor for worse survival (hazard ratio 1.22, 95% CI 1.05-1.39; P = 0.006). The incidence of PSCC in the Netherlands has been gradually increasing over the past three decades, with a noticeable trend towards centralisation of PSCC care and improved relative survival rate.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 BJU International.
Références
Fu L, Tian T, Yao K et al. Global pattern and trends in penile cancer incidence: population-based study. JMIR Public Health Surveill 2022; 8: e34874
Olesen TB, Sand FL, Aalborg GL, Munk C, Kjaer SK. Incidence of penile intraepithelial neoplasia and incidence and survival of penile cancer in Denmark, 1997 to 2018. Cancer Causes Control 2022; 33: 117-123
Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 1994; 151: 1239-1243
Campbell RA, Slopnick EA, Ferry EK, Zhu H, Kim SP, Abouassaly R. Disparity between pre-existing management of penile cancer and NCCN guidelines. Urol Oncol 2017; 35: 531.e9-531.e14
Bada M, Berardinelli F, Nyiràdy P et al. Adherence to the EAU guidelines on penile cancer treatment: European, multicentre, retrospective study. J Cancer Res Clin Oncol 2019; 145: 921-926
Woldu SL, Ci B, Hutchinson RC et al. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: a propensity-score matched analysis. Urol Oncol 2018; 36: 159.e7-159.e17
Sadeghi R, Gholami H, Zakavi SR, Kakhki VR, Tabasi KT, Horenblas S. Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature. J Urol 2012; 187: 25-31
Zou ZJ, Liu ZH, Tang LY et al. Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis. Int Urol Nephrol 2016; 48: 2001-2013
Publication overview of centers of expertise for rare diseases recognized by the Ministery of Health, Welfare and Sport. 2022
SONCOS: Multidisciplinaire Normering Oncologische Zorg in Nederland. 2022
Brouwer OR, Albersen M, Parnham A et al. European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update. Eur Urol 2023; 83: 548-560
Revision of European Standard Population; Report of Eurostat's task force (2013 edition).
Perme MP, Pavlic K. Nonparametric relative survival analysis with the R package relsurv. J Stat Softw 2018; 87: 1-27
Schoffer O, Neumann A, Stabenow R et al. Penile cancer - incidence, mortality, and survival in Saxony, Germany. Urol Oncol 2019; 37: 295.e1-295.e8
Hansen BT, Orumaa M, Lie AK, Brennhovd B, Nygård M. Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015. Int J Cancer 2018; 142: 1586-1593
Arya M, Li R, Pegler K et al. Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control 2013; 24: 2169-2176
Philippou P, Shabbir M, Malone P et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol 2012; 188: 803-808
Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 2008; 54: 161-168
Roussel E, Peeters E, Vanthoor J et al. Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma? BJU Int 2021; 127: 606-613
Bayles AC, Sethia KK. The impact of improving outcomes guidance on the management and outcomes of patients with carcinoma of the penis. Ann R Coll Surg Engl 2010; 92: 44-45
Tang V, Clarke L, Gall Z et al. Should centralized histopathological review in penile cancer be the global standard? BJU Int 2014; 114: 340-343
Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003; 170: 783-786
Ayres BE, Hounsome L, Alnajjar H, Sharma DM, Verne J, Watkin N. Has centralisation of penile cancer services in the United Kingdom improved survival? Eur Urol Suppl 2014; 13: e50
Ulvskog E, Persson EK, Kirrander P, Fall K, Ahlgren J. Nationwide data support centralised decision-making in penile cancer care: a before-and-after study on guideline adherence and disease-specific survival for patients with an indication for perioperative oncological treatment. Eur Urol Open Sci 2023; 51: 70-77
Olesen TB, Sand FL, Rasmussen CL et al. Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol 2019; 20: 145-158